acetoneberberine

structure

Networked: 1 relevant articles (0 outcomes, 0 trials/studies)

1.	Chowdhury, Shahead Ali: 1 article (11/2005)
2.	Fujisawa, Sei-Ichiro: 1 article (11/2005)
3.	Inoue, Kanako: 1 article (11/2005)
4.	Ishihara, Mariko: 1 article (11/2005)
5.	Kulsum, Umme: 1 article (11/2005)
6.	Sakagami, Hiroshi: 1 article (11/2005)
7.	Yokoe, Ichiro: 1 article (11/2005)

1.	Neoplasms (Cancer) 11/01/2005 - "Berberine iodide (IK-1) and acetoneberberine (IK-2) showed higher cytotoxicity against five human oral squamous cell carcinoma (HSC-2, HSC-3, HSC-4, NA, CA9-22) and one human promyelocytic leukemia (HL-60) cell lines, than against normal human oral tissue-derived cells (gingival fibroblast HGF, pulp cell HPC, periodontal ligament fibroblast HPLF), producing a tumor specificity index of 4.0 and 3.6, respectively. "
2.	Leukemia 11/01/2005 - "Berberine iodide (IK-1) and acetoneberberine (IK-2) showed higher cytotoxicity against five human oral squamous cell carcinoma (HSC-2, HSC-3, HSC-4, NA, CA9-22) and one human promyelocytic leukemia (HL-60) cell lines, than against normal human oral tissue-derived cells (gingival fibroblast HGF, pulp cell HPC, periodontal ligament fibroblast HPLF), producing a tumor specificity index of 4.0 and 3.6, respectively. "
3.	Squamous Cell Carcinoma of Head and Neck 11/01/2005 - "Berberine iodide (IK-1) and acetoneberberine (IK-2) showed higher cytotoxicity against five human oral squamous cell carcinoma (HSC-2, HSC-3, HSC-4, NA, CA9-22) and one human promyelocytic leukemia (HL-60) cell lines, than against normal human oral tissue-derived cells (gingival fibroblast HGF, pulp cell HPC, periodontal ligament fibroblast HPLF), producing a tumor specificity index of 4.0 and 3.6, respectively. "